Zobrazeno 1 - 10 of 511 pro vyhledávání: '"mesh:hepatitis"'
2
Cannabis Use as a Protective Factor Against Overweight in HIV-Hepatitis C Virus Co-Infected People (ANRS CO13 HEPAVIH Cohort)
Autor: Barré, Tangui, Sogni, Philippe, Zaegel-Faucher, Olivia, Wittkop, Linda, Marcellin, Fabienne, Carrieri, Patrizia, Gervais, Anne, Levier, Axel, Rosenthal, Eric, Salmon-Céron, Dominique, Protopopescu, Camelia
Publikováno v: AIDS Education and Prevention
AIDS Education and Prevention, 2022, 34 (4), pp.272-290. ⟨10.1521/aeap.2022.34.4.272⟩
International audience; Overweight is increasingly prevalent in people living with HIV (PLWH), and is a high risk factor for metabolic disorders in this population. PLWH co-infected with hepatitis C virus (HCV) have a higher risk of metabolic disorde
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90cc3dee3b453575ed93cd86c5c01cf2
https://doi.org/10.1521/aeap.2022.34.4.272
Zobrazit plný text záznamu
4
Adherence to opioid agonist therapy predicts uptake of direct-acting antivirals in people who use drugs: results from the French national healthcare database (the ANRS FANTASIO study)
Autor: Benjamin Rolland, Caroline Lions, Vincent Di Beo, Patrizia Carrieri, Nicolas Authier, Tangui Barré, Jessica Delorme, Philippe Mathurin, François Bailly, Camelia Protopopescu, Fabienne Marcellin
Publikováno v: Harm Reduction Journal
Harm Reduction Journal, 2022, 19 (1), pp.119. ⟨10.1186/s12954-022-00702-9⟩
Background Opioid agonist therapy (OAT) is associated with reduced injection, reduced HCV transmission, and more opportunities to initiate hepatitis C virus (HCV) treatment in people who use drugs (PWUD). We aimed to study the extent to which adheren
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f15f549d7eef737ecbd27ed4b3ed8808
https://www.hal.inserm.fr/inserm-04050246
Zobrazit plný text záznamu
5
Non-invasive diagnosis and follow-up of chronic infection with hepatitis B virus
Autor: Vincent Leroy, Stéphane Chevaliez, Marie Decraecker, Dominique Roulot, Jean Nana, Tarik Asselah, Xavier Causse, David Durantel, Vincent Thibaut, Nathalie Ganne-Carrié, Christophe Bureau, Victor de Lédinghen, Marc Bourlière
Publikováno v: Clinics and Research in Hepatology and Gastroenterology
Clinics and Research in Hepatology and Gastroenterology, 2022, 46 (8), pp.101773. ⟨10.1016/j.clinre.2021.101773⟩
Diagnosis of chronic hepatitis B virus (HBV) infection, initial staging of infection and monitoring of treated and untreated patients are mainly based on clinical, biological and imaging criteria allowing a complete non-invasive management for the ma
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b41635cab0a858890c0859aaf7c369a0
https://www.hal.inserm.fr/inserm-04043415/document
Zobrazit plný text záznamu
6
Hepatitis B Vaccination Coverage of Preschool Children in Libreville, Gabon: Prevalence and Determining Factors
Autor: Minto'O, Steeve, Kamgaing, E Kuissi, Bisvigou, Ulrick, Loembe, F, Nze, D Zoua, Ngoungou, Edgard Brice, Ategbo, Simon
Publikováno v: Indian Pediatrics
Indian Pediatrics, Springer Verlag, 2022, 59 (4), pp.290-292
International audience; Objective: We aimed to assess hepatitis B vaccination coverage (vaccine coverage) among preschool children in Libreville, Gabon, and determine associated factors.Methods: A cross-sectional study was done evaluating hepatitis B
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::cb6c237f2b7ec61e6e176b2328daeb83
https://hal-unilim.archives-ouvertes.fr/hal-03692224
Zobrazit plný text záznamu
7
Viral hepatitis and pregnancy
Autor: Miriam T. Levy, Norah A. Terrault, Ka Wang Cheung, Gonzague Jourdain
Publikováno v: Nature reviews. Gastroenterology & hepatology
Nature reviews. Gastroenterology & hepatology, Nature Publishing Group, 2009-, 2021, 18 (2), pp.117-130. ⟨10.1038/s41575-020-00361-w⟩
The management of viral hepatitis in the setting of pregnancy requires special consideration. There are five liver-specific viruses (hepatitis A, B, C, D, E), each with unique epidemiology, tendency to chronicity, risk of liver complications and resp
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eb6fad6214b95c2f49dd0ce7c1960257
https://doi.org/10.1038/s41575-020-00361-w
Zobrazit plný text záznamu
8
Update
Autor: Michael A. Purdy, Helene Norder, Gábor Reuter, Florence Nicot, Peter Simmonds, Jacques Izopet, Shahid Jameel, Donald B. Smith, Wim H.M. van der Poel, Xiang-Jin Meng, Hiroaki Okamoto
Publikováno v: The Journal of General Virology
The Journal of general virology 101 (2020) 7
Journal of General Virology
Journal of General Virology, Microbiology Society, 2020, 101 (7), pp.692-698. ⟨10.1099/jgv.0.001435⟩
The Journal of general virology, 101(7), 692-698
In this recommendation, we update our 2016 table of reference sequences of subtypes of hepatitis E virus (HEV; species Orthohepevirus A, family Hepeviridae) for which complete genome sequences are available (Smith et al., 2016). This takes into accou
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad8d78d6744cad542962c470ecb63b76
http://europepmc.org/articles/PMC7660235
Zobrazit plný text záznamu
9
Does HEV‐3 subtype play a role in the severity of acute hepatitis E?
Autor: Jacques Izopet, Jean-Marie Péron, Mathilde Castanier, Florence Abravanel, Sébastien Lhomme, Nassim Kamar, Chloé Dimeglio
Publikováno v: Liver International
Liver International, 2020, 40 (2), pp.333-337. ⟨10.1111/liv.14329⟩
International audience; Hepatitis E virus genotype 3 (HEV-3) is a major aetiologic agent of acute hepatitis in industrialized countries. Two main HEV-3 subtypes are found in Europe: subtypes 3c and 3f. We have analysed the clinical and biological par
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f34276b83878045cd320a565ac322ecc
https://doi.org/10.1111/liv.14329
Zobrazit plný text záznamu
10
Machine Learning-Based Single Cell and Integrative Analysis Reveals That Baseline mDC Predisposition Correlates With Hepatitis B Vaccine Antibody Response
Autor: Brian D. Aevermann, Casey P. Shannon, Mark Novotny, Rym Ben-Othman, Bing Cai, Yun Zhang, Jamie C. Ye, Michael S. Kobor, Nicole Gladish, Amy Huei-Yi Lee, Travis M. Blimkie, Robert E. Hancock, Alba Llibre, Darragh Duffy, Wayne C. Koff, Manish Sadarangani, Scott J. Tebbutt, Tobias R. Kollmann, Richard H. Scheuermann
Publikováno v: Frontiers in Immunology
Frontiers in Immunology, Frontiers, 2021, 12, pp.690470. ⟨10.3389/fimmu.2021.690470⟩
Frontiers in Immunology, 2021, 12, pp.690470. ⟨10.3389/fimmu.2021.690470⟩
Frontiers in Immunology, Vol 12 (2021)
International audience; Vaccination to prevent infectious disease is one of the most successful public health interventions ever developed. And yet, variability in individual vaccine effectiveness suggests that a better mechanistic understanding of v
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c750a2878091c4b59d184e48a27bfc79
https://hal-pasteur.archives-ouvertes.fr/pasteur-03517632/file/fimmu-12-690470.pdf
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje